One of Fitbit's founders, James Park, the company's CEO, talked about the company's plans to enter the health care field at a recent Quartz event in San Francisco. This is related to the news that Fitbit announced a partnership with medical technology company Medtronic.

At a time when the public eye is still focused on Fitbit's acquisition of smart watch maker Pebble's assets, Park hopes to turn its attention to the company's medical-centric future plan.

"With a Fitbit should save your life," he said, and firmly believes that wearable devices are currently just the trend, but in the future may become a form of medical care. According to Park, clearly linking daily activities, physical exercise and blood sugar levels will be the company's next step.

Last June, Fitbit's initial public offering (IPO) was extremely successful, but its share price has since fallen from $47.60 per share in July last year to a staggering $8. Obviously, the acquisition of Pebble's software and intellectual property can increase its product line and help the stock price pick up. Achieving a deal with Medtronic, a leader in healthcare, will enable the company's market to be more than just a fitness madman, but to build a strategic partnership between the two parties to reduce Fitbit's reliance on the average consumer.

In terms of production, Fitbit has begun to use robots to assemble microscopic equipment. “We are beginning to fully automate the company’s product manufacturing,” Park said. He added that in the near future, Fitbit will focus more on sensor and artificial intelligence (AI), and look forward to achieving technical fine-tuning. Improve the reliability of health monitoring.

Angio Closure Pad

medical Angio Closure Pad,angio syringe,Angio Closure Pad

Anesthesia Medical Co., Ltd. , https://www.jssinoanesthesia.com